Vilanterol Trifenatate / Fluticasone Furoate Inhalation Powder 200mcg (Relvar Ellipta® / レルベア200エリプタ14吸入用)

JPY ¥7,600

Japanese combination asthma treatment agent (Vilanterol Trifenatate / Fluticasone Furoate 200mcg). Once-daily inhalation for bronchial asthma requiring combined ICS and long-acting beta-2 agonist therapy. 14-dose inhaler [tray with desiccant] x 1. Mfd. by GlaxoSmithKline K.K., Japan.

Bulk deal
Quantity Discount Discounted price
5 - 9 8% JPY ¥6,992
10 - 19 12% JPY ¥6,688
20 + 18% JPY ¥6,232
SKU: REL-200-INH Category:

Description

Product Overview / 商品概要

Relvar Ellipta 200mcg Inhalation Powder 14 doses (レルベア200エリプタ14吸入用)
Generic: Vilanterol Trifenatate / Fluticasone Furoate / ビランテロールトリフェニル酢酸塩・フルチカゾンフランカルボン酸エステル
Therapeutic Category: Combination Asthma Treatment Agent / 喘息治療配合剤
Manufactured by: GlaxoSmithKline K.K. / グラクソ・スミスクライン株式会社

Composition & Specification / 組成・規格

Active Ingredient: Vilanterol Trifenatate 40mcg (as Vilanterol 25mcg) and Fluticasone Furoate 200mcg per blister / 1ブリスター中 ビランテロールトリフェニル酢酸塩40μg(ビランテロールとして25μg)、フルチカゾンフランカルボン酸エステル200μg
Additives: Lactose hydrate (contains milk protein as impurity), Magnesium stearate / 乳糖水和物(夾雑物として乳蛋白を含む)、ステアリン酸マグネシウム
Appearance: White inhalation powder
外観: 白色の吸入粉末剤

Indications / 効能効果

EN: Bronchial asthma (when concurrent use of an inhaled corticosteroid and a long-acting inhaled beta-2 agonist is required)
JA: 気管支喘息(吸入ステロイド剤及び長時間作動型吸入β2刺激剤の併用が必要な場合)

Dosage and Administration / 用法用量

EN: Adults: Usually, administer 1 inhalation of Relvar Ellipta 200 (Vilanterol 25mcg and Fluticasone Furoate 200mcg) once daily by inhalation, according to symptoms.
JA: 〈気管支喘息〉成人:通常、症状に応じてレルベア200エリプタ1吸入(ビランテロールとして25μg及びフルチカゾンフランカルボン酸エステルとして200μg)を1日1回吸入投与する。

Contraindications / 禁忌

EN: Patients with infections for which no effective antibacterial agents exist, or with deep mycosis; Patients with a history of hypersensitivity to any component of this product
JA: 有効な抗菌剤の存在しない感染症、深在性真菌症の患者;本剤の成分に対し過敏症の既往歴のある患者

Regulatory Information / 規制情報

Approval No.: 22500AMX01813
Sales Started: December 2013 / 2013年12月
Classification Code: 87229
Storage: Store at room temperature / 室温保存
Shelf Life: 24 months / 24ヵ月

Packaging / 包装

Main Package (for sale): 14-dose inhaler [tray with desiccant] x 1 / 14吸入用[トレイ、乾燥剤入り]×1
Other Available Packages (by special order): Relvar Ellipta 200 14 doses: 14-dose inhaler [tray with desiccant] x 1; Relvar Ellipta 200 30 doses: 30-dose inhaler [tray with desiccant] x 1

Full product insert (添付文書) is attached as a downloadable PDF. For detailed precautions, drug interactions, and safety information, please refer to the official package insert.

Additional information

重さ 0.15 kg

Reviews

There are no reviews yet.

Be the first to review “Vilanterol Trifenatate / Fluticasone Furoate Inhalation Powder 200mcg (Relvar Ellipta® / レルベア200エリプタ14吸入用)”

メールアドレスが公開されることはありません。 ※ が付いている欄は必須項目です

Export from Japan — Vilanterol Trifenatate

🏭 Supply & Origin

  • Country of Origin: Japan
  • Regulatory Standard: PMDA (Japan) / GMP Compliant
  • Pharmacopoeia: Japanese Pharmacopoeia (JP)
  • Supplier: Mate Co., Ltd. — Licensed Pharmaceutical Wholesaler (License No. B14309, Osaka)
  • Supply Capacity: Full-line sourcing through Japan's regulated distribution channels

🚚 Shipping & Trade Terms

  • Incoterms: FOB Kansai International Airport (KIX)
  • Shipping: Air freight via B/L or AWB
  • Payment: 100% T/T in advance
  • Lead Time: 2-4 weeks after payment confirmation
  • Available Regions: EU, LATAM, APAC, Middle East, Africa

Request a Quotation

For pricing, MOQ, and regulatory documentation, contact our export team:

Email: kurimoto@mate-osaka.co.jp
Tel: +81-72-665-5736

All exports are conducted through proper regulatory procedures including customs clearance, B/L or AWB documentation, and T/T advance payment. We do not engage in hand-carry, cash transactions, or sales to unlicensed parties.